15-Hydroxyprostaglandin dehydrogenase inhibitor prevents contrast-induced acute kidney injury
Autor: | Ki Beom Bae, Dong-Hyun Kim, Sun Woo Kang, Byeong Woo Kim, Hye Jung Kim, Sanford D. Markowitz, Hyung Joo Baik, Mi Seon Kang, Sun-Hee Kim |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
contrast media acute kidney injury Pyridines media_common.quotation_subject Prostaglandin E2 030232 urology & nephrology Hemodynamics Contrast Media Thiophenes 030204 cardiovascular system & hematology Critical Care and Intensive Care Medicine Kidney Iodinated contrast media 03 medical and health sciences Mice 0302 clinical medicine 15 hydroxyprostaglandin dehydrogenase Lipocalin-2 Internal medicine Laboratory Study Triiodobenzoic Acids medicine Contrast (vision) Animals Humans media_common urogenital system business.industry Prostaglandins E Acute kidney injury General Medicine Acute Kidney Injury medicine.disease Diseases of the genitourinary system. Urology 15-PGDH inhibitor Mice Inbred C57BL Endocrinology Nephrology Creatinine Hydroxyprostaglandin Dehydrogenases Female RC870-923 medicine.symptom business Vasoconstriction medicine.drug Research Article |
Zdroj: | Renal Failure article-version (VoR) Version of Record Renal Failure, Vol 43, Iss 1, Pp 168-179 (2021) |
ISSN: | 1525-6049 0886-022X |
Popis: | The two primary mechanisms by which iodinated contrast media (CM) causes contrast-induced acute kidney injury (CIAKI) are the hemodynamic effect causing intrarenal vasoconstriction and the tubular toxic effect causing acute tubular necrosis. Inhibition of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), which degrades prostaglandin E2 (PGE2), promotes tissue repair and regeneration in many organs. PGE2 causes intrarenal arterial vasodilation. In this study, we investigated whether a 15-PGDH inhibitor can act as a candidate for blocking these two major mechanisms of CIAKI. We established a CIAKI mouse model by injecting a 10 gram of iodine per body weight (gI/kg) dose of iodixanol into each mouse tail vein. A 15-PGDH inhibitor (SW033291), PGE1, or PGE2 were administered to compare the renal functional parameters, histologic injury, vasoconstriction, and renal blood flow changes. In addition, human renal proximal tubular epithelial cells were cultured in a CM-treated medium. SW033291, PGE1, or PGE2 were added to compare any changes in cell viability and apoptosis rate. CIAKI mice that received SW033291 had lower serum levels of creatinine, neutrophil gelatinase-associated lipocalin, and kidney injury molecule 1 (p |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |